These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 13998884)

  • 1. [Trial of a new anticoagulant: 1-methoxy-2,2-bis(4-hydroxy-3-coumarinyl)-ethane. (Apropos of 27 cases)].
    WAREMBOURG H; DELOMEZ M
    Lille Med; 1963; 8():560-2. PubMed ID: 13998884
    [No Abstract]   [Full Text] [Related]  

  • 2. [A RECENT SYNTHETIC ANTICOAGULANT: DICOUMOXYL (NETHOXY-L-BIS (HYDROXY-4-COUMARINYL-3)--2,2-ETHANE)].
    GILGENKRANTZ JM; CHERRIER F; BARRUCAND D; ROYER R; RENAUD J
    Ann Med Nancy; 1964 Jan; 3():115-25. PubMed ID: 14136374
    [No Abstract]   [Full Text] [Related]  

  • 3. [STUDY OF THE THERAPEUTIC ACTION AND ANTICOAGULANT ACTIVITY OF L-METHOXY-2,2-BIS-(4-HYDROXY-3-COUMARINYL)-ETHANE (DICOUMOXYL)].
    GEOFFROY H; DAOUDI A; BENYAHIA M; BERRADA A
    Maroc Med; 1963 Aug; 42():614-6. PubMed ID: 14052100
    [No Abstract]   [Full Text] [Related]  

  • 4. [CLINICAL EXPERIMENTATION WITH A NEW SYNTHETIC ANTICOAGULANT, A COUMARIN DERIVATIVE: 1-METHOXY-2, 2-BIS (4-HYDROXY-3-COUMARINYL)-ETHANE].
    HUTINEL P
    Lyon Med; 1964 Jun; 211():1569-604. PubMed ID: 14161671
    [No Abstract]   [Full Text] [Related]  

  • 5. [USE IN CARDIOLOGY OF A NEW ANTICOAGULANT: DICOUMOXYL (1-BIS-METHOXY (4-HYDROXY, 3-COUMARINYL) 2,2-ETHANE). APROPOS OF 29 CASES].
    MERIEL P; GALINIER F; BOUNHOURE JP; GAVALDA J
    Toulouse Med; 1964; 65():849-58. PubMed ID: 14204295
    [No Abstract]   [Full Text] [Related]  

  • 6. [CRITICAL STUDY, BASED ON 43 CASES, OF A COUMARIN ANTICOAGULANT: DICOUMOXYL (1-METHOXY-2,2-BIS-(4-HYDROXY-3-COU- MARINYL)-ETHANE)].
    FAIVRE G; GILGENKRANTZ JM; CHERRIER F; TENETTE C; BARRUCAND D
    Sem Hop; 1963 Nov; 39():2392-9. PubMed ID: 14095600
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trial of a new anticoagulant derived from coumarin: 1-methoxy-2, 2-bis(4-hydroxy-3-coumarinyl)-ethane].
    DELAHAYE JP; PLAUCHU G; FROMENT A
    Lyon Med; 1963 May; 209():1147-59. PubMed ID: 14026605
    [No Abstract]   [Full Text] [Related]  

  • 8. [Critical study of the use of a new anticoagulant, derived from coumarin: dicoumoxyl, 1-methoxy-2,2-bis (4-hydroxy-3-coumarinyl)-ethane].
    DELBOY C
    Gaz Med Fr; 1963 Feb; 70():735-42. PubMed ID: 14026667
    [No Abstract]   [Full Text] [Related]  

  • 9. [USE OF A NEW ANTICOAGULANT: THIOPORAN. EXPERIENCE WITH 50 CASES].
    FAIVRE G; GILGENKRANTZ JM; CHERRIER JM; ROYER R; REBEIX G
    Ann Med Nancy; 1963 Jun; 2():1003-10. PubMed ID: 14067482
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of a new synthetic anticoagulant, methoxy-l-bis (hydroxy-4-coumarinyl-3) 2,2 ethane].
    AMOURETTI M; BELLET M
    J Med Bord; 1962 Dec; 139():1729-32. PubMed ID: 14012654
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trial with a new synthetic anticoagulant: methoxy-1-bis (hydroxy-4-coumarinyl-3)2,2-ethane].
    SIKORAV H; WIART JP
    Sem Hop; 1962 Mar; 38():1002-5. PubMed ID: 13912779
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the anticoagulant action of a new derivative of coumarin: Dicoumoxyl (Methoxy-1-bis-hydroxy-4-coumarinyl 3)-2,2 ethane)].
    NEEL JL
    Gaz Med Fr; 1962 Nov; 69():3313-6. PubMed ID: 13937881
    [No Abstract]   [Full Text] [Related]  

  • 13. [Practical use of anti-prothrombin treatments].
    Chiche P; Berkman M; Savier CH
    Sem Ther; 1967 Oct; 43(8):448-9. PubMed ID: 5623992
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myocardial infarction evolving under anticoagulant treatment (apropos of 4 cases)].
    FAIVRE G; GILGENKRANTZ JM; CHERRIER F; TENETTE C; GAUCHER P; ANTHOINE D
    Ann Med Nancy; 1962 Jun; 1():225-40. PubMed ID: 13891368
    [No Abstract]   [Full Text] [Related]  

  • 15. [STUDY OF DICOUMOXYL, 1-METHOY-2,2-BIS(4-HYDROXY-3-COUMARINYL)-ETHANE, IN SURGERY].
    VALLET G
    Ann Chir; 1963 Dec; 17():1645-8. PubMed ID: 14108982
    [No Abstract]   [Full Text] [Related]  

  • 16. [FUNDAMENTAL PRINCIPLES OF ANTICOAGULANT THERAPY].
    DOCZY P; SZIGETI I
    Med Interna (Bucur); 1965 Jun; 17():641-50. PubMed ID: 14336280
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical action of the new anticoagulants, 2-2-bis-(4-hydroxy-3-coumarinyl)-ethanol ethers].
    DEKKER E; GROEN J
    Ned Tijdschr Geneeskd; 1954 Jul; 98(28):1928-32. PubMed ID: 13185356
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulants in coronary artery disease.
    Lee LV
    Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulant and thrombolytic agents in acute coronary syndrome].
    Saurbier B; Bode C
    Hamostaseologie; 2005 Nov; 25(4):333-44. PubMed ID: 16395483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consideration of the 24-lead electrocardiogram to provide ST-elevation myocardial infarction equivalent criteria for acute coronary occlusion.
    Wagner G; Pahlm O; Selvester R
    J Electrocardiol; 2006 Oct; 39(4 Suppl):S62-7. PubMed ID: 17015069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.